These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. GeVIR is a continuous gene-level metric that uses variant distribution patterns to prioritize disease candidate genes. Abramovs N; Brass A; Tassabehji M Nat Genet; 2020 Jan; 52(1):35-39. PubMed ID: 31873297 [TBL] [Abstract][Full Text] [Related]
5. Inheritance-mode specific pathogenicity prioritization (ISPP) for human protein coding genes. Hsu JS; Kwan JS; Pan Z; Garcia-Barcelo MM; Sham PC; Li M Bioinformatics; 2016 Oct; 32(20):3065-3071. PubMed ID: 27354691 [TBL] [Abstract][Full Text] [Related]
6. Deregulated Regulators: Disease-Causing cis Variants in Transcription Factor Genes. van der Lee R; Correard S; Wasserman WW Trends Genet; 2020 Jul; 36(7):523-539. PubMed ID: 32451166 [TBL] [Abstract][Full Text] [Related]
7. Computational approaches to disease-gene prediction: rationale, classification and successes. Piro RM; Di Cunto F FEBS J; 2012 Mar; 279(5):678-96. PubMed ID: 22221742 [TBL] [Abstract][Full Text] [Related]
8. A practical guide to filtering and prioritizing genetic variants. Jalali Sefid Dashti M; Gamieldien J Biotechniques; 2017 Jan; 62(1):18-30. PubMed ID: 28118812 [TBL] [Abstract][Full Text] [Related]
9. Deep sequencing of Danish Holstein dairy cattle for variant detection and insight into potential loss-of-function variants in protein coding genes. Das A; Panitz F; Gregersen VR; Bendixen C; Holm LE BMC Genomics; 2015 Dec; 16():1043. PubMed ID: 26645365 [TBL] [Abstract][Full Text] [Related]
10. A visual and curatorial approach to clinical variant prioritization and disease gene discovery in genome-wide diagnostics. James RA; Campbell IM; Chen ES; Boone PM; Rao MA; Bainbridge MN; Lupski JR; Yang Y; Eng CM; Posey JE; Shaw CA Genome Med; 2016 Feb; 8(1):13. PubMed ID: 26838676 [TBL] [Abstract][Full Text] [Related]
11. Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation. Traynelis J; Silk M; Wang Q; Berkovic SF; Liu L; Ascher DB; Balding DJ; Petrovski S Genome Res; 2017 Oct; 27(10):1715-1729. PubMed ID: 28864458 [TBL] [Abstract][Full Text] [Related]
12. Mining the coding and non-coding genome for cancer drivers. Li J; Drubay D; Michiels S; Gautheret D Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Tools and Databases to Assess the Pathogenicity of Mitochondrial DNA Variants in the Field of Next Generation Sequencing. Bris C; Goudenege D; Desquiret-Dumas V; Charif M; Colin E; Bonneau D; Amati-Bonneau P; Lenaers G; Reynier P; Procaccio V Front Genet; 2018; 9():632. PubMed ID: 30619459 [TBL] [Abstract][Full Text] [Related]
15. New insights into the pathogenicity of non-synonymous variants through multi-level analysis. Sun H; Yu G Sci Rep; 2019 Feb; 9(1):1667. PubMed ID: 30733553 [TBL] [Abstract][Full Text] [Related]
16. VarElect: the phenotype-based variation prioritizer of the GeneCards Suite. Stelzer G; Plaschkes I; Oz-Levi D; Alkelai A; Olender T; Zimmerman S; Twik M; Belinky F; Fishilevich S; Nudel R; Guan-Golan Y; Warshawsky D; Dahary D; Kohn A; Mazor Y; Kaplan S; Iny Stein T; Baris HN; Rappaport N; Safran M; Lancet D BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):444. PubMed ID: 27357693 [TBL] [Abstract][Full Text] [Related]
17. Identification of Disease Susceptibility Alleles in the Next Generation Sequencing Era. DiStefano JK; Kingsley CB Methods Mol Biol; 2018; 1706():3-16. PubMed ID: 29423790 [TBL] [Abstract][Full Text] [Related]